Sign in

CIK 0000914475

  • Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330525145
Phone
+1 858-617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-31 ABERNETHY MATT Chief Financial Officer Grant or award · Stock Option +66,362 66,362
2022-01-31 ABERNETHY MATT Chief Financial Officer Grant or award · Restricted Stock Unit +9,745 9,745
2022-01-31 ROBERTS EIRY Chief Medical Officer Grant or award · Stock Option +75,411 75,411
2022-01-31 ROBERTS EIRY Chief Medical Officer Grant or award · Restricted Stock Unit +11,074 11,074
2022-01-31 GORMAN KEVIN CHARLES Chief Executive Officer Grant or award · Stock Option +140,049 140,049
2022-01-31 GORMAN KEVIN CHARLES Chief Executive Officer Grant or award · Restricted Stock Unit +20,565 20,565
2022-01-24 SHERWIN STEPHEN A Director Option exercise +15,000 $6.66 $100K 40,055
2022-01-24 SHERWIN STEPHEN A Director Sale −15,000 $74.43 $1.1M 25,055
2022-01-24 SHERWIN STEPHEN A Director Option exercise · Non-Qualified Stock Option −15,000 $6.66 $100K 0
2022-01-10 ROBERTS EIRY Chief Medical Officer Sale −2,632 $74.50 $196K 21,279
2022-01-05 Gano Kyle Chief Business Development Off Option exercise +28,266 $8.66 $245K 133,250
2022-01-05 Gano Kyle Chief Business Development Off Sale −28,266 $85.50 $2.4M 104,984
2022-01-05 Gano Kyle Chief Business Development Off Option exercise · Non-Qualified Stock Option −28,266 $8.66 $245K 0
2021-12-14 SHERWIN STEPHEN A Director Gift −2,000 25,055
2021-12-10 Lippoldt Darin Chief Legal Officer Gift −120 34,448
2021-12-01 ABERNETHY MATT Chief Financial Officer Sale −1,645 $82.59 $136K 16,349
2021-11-29 Onyia Jude Chief Scientific Officer Grant or award · Stock Option +120,169 120,169
2021-11-29 Onyia Jude Chief Scientific Officer Grant or award · Restricted Stock Unit +17,702 17,702
2021-10-07 LYONS GARY A Director Sale −5,000 $105.06 $525K 208,697
2021-10-07 Grigoriadis Dimitri E. Chief Research Officer Sale −3,000 $104.75 $314K 82,273

Page 57 of 62 · 1,221 trades